8-K//Current report
Adaptimmune Therapeutics PLC 8-K
Accession 0001104659-25-100618
$ADAPCIK 0001621227operating
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 7:50 AM ET
Size
194.0 KB
Accession
0001104659-25-100618
Documents
- 8-Kadap-20251015x8k.htmPrimary
8-K
- EX-99.1adap-20251015xex99d1.htm
EX-99.1
- GRAPHICadap-20251015xex99d1001.jpg
GRAPHIC
- GRAPHICadap-20251015xex99d1002.jpg
GRAPHIC
- EX-101.SCHadap-20251015.xsd
EX-101.SCH
- EX-101.LABadap-20251015_lab.xml
EX-101.LAB
- EX-101.PREadap-20251015_pre.xml
EX-101.PRE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-25-100618-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLadap-20251015x8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 7:50 AM ET
- Size
- 194.0 KB